Mads Gyrd-Hansen
@gyrd73
Followers
177
Following
4
Media
0
Statuses
33
I am a group leader at Ludwig Cancer Research in Oxford. I am interested in ubiquitin signalling in immune responses and inflammation-associated cancer.
Oxford, England
Joined February 2014
Journal-independent peer review platform @ReviewCommons ensures referees focus on the science rather than journal fit. Authors choose the right journal fit first time based on objective & structured referee feedback. https://t.co/OwYJyauSn0
#PeerRevWk20 #TrustInPeerReview @EMBO
reviewcommons.org
Improve your paper and streamline publication through journal-independent peer-review.
0
14
11
I am delighted to be joining the Leo Foundation Skin Immunology Research Centre and look very much forward to build up a new research team to study Ubiquitin signaling in skin immunology, inflammation and cancer. Honoured to be awarded a Young Investigator award by NNF.
@gyrd73 will explore how the skin and the immune system interact in diseases such as psoriasis and skin cancer. #skinresearch #dkforsk @skinucph @novonordiskfond
10
3
41
Acetylation-Dependent Deubiquitinase OTUD3 Controls MAVS Activation in Innate Antiviral Immunity
0
2
18
Ludwig's Oxford Branch is looking for a new Group Leader in cancer epigenetics, a position at the assistant or associate professor level at Oxford! Aside from related experience, applicants should have a PhD or MD and a record of strong publications.
0
2
3
Good decision - would have liked to see implemented sooner. Key is to reduce transmission & new infections as soon as possible & get as close as possible to “elimination” before autumn.
bbc.co.uk
The health secretary says the new rule aims to give shoppers confidence and protect retail staff.
44
242
1K
Oxford’s Covid-19 vaccine, devised by Sarah Gilbert, is in human trials. AstraZeneca has lined up agreements to produce 2 billion doses. Now the world waits https://t.co/pX3lt1rXAG via @BW
bloomberg.com
The University of Oxford candidate, led by Sarah Gilbert, might be through human trials in September. AstraZeneca has lined up agreements to produce 2 billion doses. Could this be the one?
1
32
106
Sascha Roth (@sasomroth) from the @sapkota_mrcppu lab demonstrates targeted degradation of endogenous K-RAS. Read the full story here: https://t.co/GQjdmKfj33
#research
0
4
18
UK COVID-19 trials show Oxford vaccine could offer 'double protection' against virus
3
14
19
Our study on mechanism of RIPK2 inhibitors in ubiquitin-mediated inflammation is available at @embojournal Congrats to Matous and Lisa! https://t.co/Bg4kAKYJ6H
3
16
29
Congrats to Ludwig San Diego's Don Cleveland, who won the Breakthrough award for elucidating the cause of an inherited ALS and for developing "designer DNA" drugs for ALS and Huntington's disease @UCSDHealth
https://t.co/q7mIIVLsj3
https://t.co/RYfg15O0sa
1
15
26
Congratulations to Ludwig’s Arshad Desai and Karen Oegema, newly appointed @ASCBiology Fellows!
1
2
5
Ludwig Stanford director Irv Weissman and his team report a second mechanism by which cancer cells avoid being eaten by the immune system's macrophages - and this one too can be disabled.
1
3
6
New issue! https://t.co/ye9kiMN3jk
#cancer evolution & selection, #microbiome & health, #mitochondria transcription, #immunity, and more!
0
1
6
Study led by Benoit Van den Eynde of Ludwig Brussels reveals a new mechanism by which #Melanoma can evade #immunotherapy -- and an approach to undoing that mechanism
1
2
3
New studies linking microbiome species/diversity to #immunotherapy effectiveness may help explain why treatment doesn't work for everyone
Gut bacteria 'boost' cancer therapy
0
1
4
New findings point to long-term use of aspirin as a prevention strategy for gastrointestinal cancer
0
4
2
#Ubiquitin regulation @MolecularCel
#Met1-Linked Ub Machinery @Ludwig_Cancer Gyrd-Hansen @OxfordMedSci @gyrd73
https://t.co/PORcWE8Ddb
0
1
2
Vacancy for a Postdoctoral Research Scientist – Immunology/Infection Biology:
ndm.ox.ac.uk
The Nuffield Department of Medicine has many exciting opportunities for researchers and support staff at various stages of their careers.
0
14
6
Could @OxSightUK's glasses give sight back to 100 million people? #StartedInOxford #Innovation
https://t.co/WOI9NaX0na
2
29
35